Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2017

View Archived Issues

FDA clinical hold on Concert Pharmaceuticals' trial of CTP-543 lifted

FDA gives orphan drug status to Boston Biomedical's DSP-7888

Prexton Therapeutics begins phase II testing of Parkinson's disease candidate

YH-18421 shows promise in diabetic mouse model

Global Blood Therapeutics expands phase IIa study of GBT-440

Immuron presents promising interim analysis results from phase II NASH trial of IMM-124E

Hemispherx gives update on early access program of Ampligen in pancreatic cancer

Lilly's abemaciclib NDA granted priority review by FDA

PDS and Merck & Co. sign clinical trial collaboration to study PDS-0101 with Keytruda

Eculizumab as potential therapy for certain forms of protein-losing enteropathy

Boehringer Ingelheim Pharma patents polypeptides targeting LRP5 and LRP6

Phenex Pharmaceuticals reaches milestone in Janssen collaboration

Anti-shingles nanoviricides drug candidates inhibit infection ex vivo

Long-acting human GLP-1 analogue BPI-3016 demonstrates promise in preclinical studies

Vaccines targeting personal tumor neoantigens show promise in patients with melanoma

Race Oncology, TargImmune create joint venture

Merus shareholders vote in favor of Norgine transaction

Enterome and Nestle Health create Microbiome Diagnostics Partners

Medicure exercises option to acquire additional interests in Apicore

G47DELTA designated a Japanese orphan drug for malignant glioma

Scancell updates SCIB-1 progress in melanoma

Arena reports phase II results for ralinepag in PAH

Alimera secures rights to Iluvien for posterior uveitis in E.U.

Neothetics seeks strategic alternatives

Sanofi set to acquire Protein Sciences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...